Keyphrases
Proton Pump Inhibitors
100%
Risk of Death
100%
Longitudinal Observational Study
100%
United States Veterans
100%
H2 Blockers
25%
Excess Risk
8%
Gastrointestinal Diseases
8%
United States Department of Veterans Affairs
4%
Adverse Events
4%
Duration of Use
4%
Matched Cohort
4%
All-cause Mortality
4%
Propensity Score Matching
4%
Exposure Time
4%
Prolonged Duration
4%
New User
4%
Two-stage Residual Inclusion
4%
Histamine-2 Receptor Antagonists (H2RA)
4%
High-dimensional Propensity Score
4%
Time-dependent Propensity Score
4%
Mathematics
Excess Risk
100%
Median
50%
Residuals
50%
Longitudinal Design
50%
Risk Measure
50%
IQR
50%
Medicine and Dentistry
Cohort Study
100%
Proton-Pump Inhibitor
100%
H2 Antagonist
29%
Veterans Affairs
4%
Adverse Event
4%
All Cause Mortality
4%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Proton Pump Inhibitor
100%
Histamine H2 Receptor Antagonist
29%
Adverse Event
4%
All Cause Mortality
4%
Neuroscience
Proton Pump Inhibitor
100%
H2 Antagonist
29%